TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in Chinese city of Wuhan has caused around 906,092 deaths and 28,040,853 confirmed cases worldwide (https://covid19.who.int/, 11 September 2020). In a life-threatening situation, where there is no specific and licensed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arab J Chem
Main Authors: Ansari, Mohammad Azam, Jamal, Qazi Mohammad Sajid, Rehman, Suriya, Almatroudi, Ahmad, Alzohairy, Mohammad A., Alomary, Mohammad N., Tripathi, Takshashila, Alharbi, Ali H., Adil, Syed Farooq, Khan, Mujeeb, Shaheer Malik, M.
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier B.V. on behalf of King Saud University. 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527303/
https://ncbi.nlm.nih.gov/pubmed/34909057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arabjc.2020.09.037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados